reports
Stellantis to Participate in Bernstein 40th Annual Strategic Decision...
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference AMSTERDAM, May 21, 2024 – Carlos Tavares, Stellantis Chief Executive Officer, will participate in a fireside chat on Wednesday, May 29, 2024, at 9:00 a.m. EDT / 3:00 p.m. CEST at the Bernstein 40th Annual Strategic Decisions Conference. To watch the live session, visit the following webcast link: Details for watching the fireside chat are also available under the section of the Stellantis corporate website. For those unab...
Munchener Ruckversicherungs-Gesellschaft AG: 1 director
A director at Munchener Ruckversicherungs-Gesellschaft AG bought 110 shares at 457.800EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Jinyoung Co Ltd: 1 director
A director at Jinyoung Co Ltd sold 43,103 shares at 3,404.346KRW and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Clearside Biomedical Announces Publication of Consensus Guidelines for...
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® - Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Current Clinical Evidence and Physician Experience Support SCS Injection as a Safe and Effective Method for Delivering Retinal and Choroidal Therapeutics - ALPHARETTA, Ga., May 21, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical compan...
Xtract One Announces Fiscal 2024 Third Quarter Conference Call
Xtract One Announces Fiscal 2024 Third Quarter Conference Call TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced that it will release fiscal 2024 third quarter results after the close of trading on June 6, 2024. Peter Evans, Xtract One CEO and Director, and Karen Hersh, CFO and Corporate Secretary, will host a webcast and conference call at 10:00 a.m. Ea...
Copenhagen Capital A/S – Periodemeddelelse for 1. kvartal 2024
Copenhagen Capital A/S – Periodemeddelelse for 1. kvartal 2024 Copenhagen Capital A/S afgiver periodemeddelelse for 1. kvartal 2024. Selskabet offentliggør ikke finansiel information som en del af periodemeddelelser. Driften af ejendommene forløber som forventet. Selskabet har i perioden haft fortsat fokus på drift af porteføljen og tomgangen er lav. Selskabet er arbejder med projekteringen og indhentning af priser for tagboligprojektet på Ole Suhrs Gade 13-15, København K. Selskabet har i perioden tilbagekøbt de resterende 8.684.791 stk. 8% Præferenceaktier 2024. Aktierne ble...
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of...
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced that it intends to offer, subject to market conditions and other factors, $500,000,000 aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). BlackLine also intends to grant the initial purchaser of the notes a 13-day option to purchase...
Tejas Networks Ltd: 5 directors
Seven Directors at Tejas Networks Ltd sold 17,657 shares at between 1,145.102INR and 1,224.455INR. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Lands...
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 WINSTON-SALEM, N.C., May 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), will host a virtual KOL event on Tuesday, May 28, 2024 at 8:00 AM ET, featuring Steven G. Coca, DO, MS (Icahn School of Medicine at Mount Sinai) and Arnold L. Silva, MD, PhD (University of Arizon...
Planet Fitness’ High School Summer Pass™ Returns; Teens Work Out Free ...
Planet Fitness’ High School Summer Pass™ Returns; Teens Work Out Free June 1 – August 31 New study finds that ninety per cent of Canadian teens believe physical activity can positively impact their lives and boost mental health1 TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- , one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, announces the return of its High School Summer Pass™ program, inviting high school teens ages 14 – 192 to work out for free at any of its 2,500+ Planet Fitness locations across the U.S. and...
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease...
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits colitis disease progression and colon inflammation, lowers inflammatory mucosal cytokines, and reduces expression of IBD-associated genes in a colitis model Initiation of MRT-6160 Phase 1 SAD/MAD study anticipated in mid-year 2024 with Phase 1 clinical data expected in Q1 2025 Poster presentation today at 12:30 pm ET BOSTON, May 21, 2024 (GLOBE NEWSWIRE) -- (Nasd...
Balchem Corporation to Attend the Deutsche Bank Global Consumer Confer...
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024 MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, and Martin Bengtsson, Chief Financial Officer will attend the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients ...
LAVA Provides Business Updates and Reports First Quarter 2024 Financia...
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024Received $7.0 million clinical development milestone from Pfizer for PF-08046052 (formerly LAVA-1223) in Phase 1LAVA-1266 on track for Q2 2024 IND submissionStrong balance sheet with cash of $94.6 million supports runway into 2026 UTRECHT, The Netherlands and PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LVTX, “LAVA,” “the Company”), a clinical-stage immuno-oncolog...
KANZHUN LIMITED Announces First Quarter 2024 Financial Results
KANZHUN LIMITED Announces First Quarter 2024 Financial Results BEIJING, May 21, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced its unaudited financial results for the quarter ended March 31, 2024. First Quarter 2024 Highlights Revenues for the first quarter of 2024 were RMB1,703.8 million (US$236.0 million), an increase of 33.4% from RMB1,277.5 million for the same quarter of 2023.Calculated cash billings1 for the first quarter of 2024 were RMB2,050.7 million (US$284.0 mi...
PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal P...
PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal Proceedings MONTREAL, May 21, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. () (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce that its wholly-owned subsidiary Pyro Green-Gas Inc. and certain related persons (collectively, the “PGG Parties”) have settled all o...
BioXcel Therapeutics Announces Oral and Poster Presentations at the 20...
BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting NEW HAVEN, Conn., May 21, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that Rob Risinger, M.D., Chief Medical Officer of Neuroscience, will deliver oral and poster presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting. The meeting will ...
American Shared Hospital Services Announces Annual Shareholder Meeting...
American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024 Meeting Will be Held at The Hilton Hotel, San Francisco, CA SAN FRANCISCO, May 21, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that its Annual Meeting of Shareholders will be held on Tuesday, June 25, 2024, at 9:00 a.m. PT. The Annual Meeting will be an in-person meeting. For tho...
BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Gras...
BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Grassy Mountain Gold and Silver Mine WINNEMUCCA, Nev., May 21, 2024 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) is pleased to announce its proposed Grassy Mountain gold mine will have the benefit of a joint reclamation bond between the Oregon Department of Geology and Mineral Industries (the “DOGAMI”) and the Bureau of Land Management (“BLM”). The two agencies have executed a Memorandum of Understanding (“MOU”) which ensures that Paramount will not be required to post ...
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Dire...
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors DUBLIN, Ireland, May 21, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today the appointment of Naseem Amin, M.D. to its board of directors, effective May 17, 2024. Dr. Amin, a highly successful executive who brings global industry and leadership experience to Avadel, currently serves as Chief Executive Officer of Orphalan SA. “On behalf of the entire Avadel team, we are excited to welcome Dr. Amin to...
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional...
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference Miami, FL, May 21, 2024 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that the Company will attend the B. Riley Securities 24th Annual Institutional Investor Conference in Beverly Hills, CA on Thursday, May 23, 2024. About Tecnoglass Tecnoglass Inc. is a leading producer of high-end aluminum and vinyl windo...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.